The latest price target for ClearPoint Neuro (NASDAQ:CLPT) was reported by Stifel on March 13, 2024. The analyst firm set a price target for $9.00 expecting CLPT to rise to within 12 months (a possible 19.68% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for ClearPoint Neuro (NASDAQ:CLPT) was provided by Stifel, and ClearPoint Neuro reiterated their buy rating.

There is no last upgrade for ClearPoint Neuro

There is no last downgrade for ClearPoint Neuro.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ClearPoint Neuro, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ClearPoint Neuro was filed on March 13, 2024 so you should expect the next rating to be made available sometime around March 13, 2025.

While ratings are subjective and will change, the latest ClearPoint Neuro (CLPT) rating was a reiterated with a price target of $8.00 to $9.00. The current price ClearPoint Neuro (CLPT) is trading at is $7.52, which is out of the analyst’s predicted range.